Obesity Research Roundup for Primary Care: 5 Studies At-a-Glance from ObesityWeek® 2022

Slideshow

Treatment options for patients with obesity have come a long way in recent years and more therapies are in development across the pharmaceutical industry. The vast majority of obesity, however, goes untreated. The Obesity Society's annual meeting, ObesityWeek® 2022, focused on ways to bridge the gap and scale up obesity treatment. Below, find briefs on 5 clinical trials presented at the meeting that may impact your clinical practice.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.